Skip to content
★ Sign in to follow
SA
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€2.3M

Latest filing published 10 May 2018 for Neogenomics INC, €135k.

Filing timeline

BuySale
Steven A. Ross

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

Steven A. Ross: trading record in brief

Steven A. Ross appears in our data through filings on Neogenomics Inc shares, published by SEC (Form 4). The record holds 15 filings, for trades running from 29 April 2016 to 10 May 2018.

On the market, this insider has only sold: 7 sales, €2.3M in total. Outside the open market, there are 8 option exercises. 2018 to date brings no purchases and 1 sale.

The record was last updated on 10 May 2018 with an open-market sale (€742k) in Neogenomics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Steven A. Ross

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◇
    CIOExecutivesNeogenomics Inc
    160,928 USD11SEC
    33,667 shares@ US$4.783.8% of flowCommon StockSEC:0001077183-18-000019:0
  • ◇
    CIOExecutivesNeogenomics Inc
    190,662 USD11SEC
    26,666 shares@ US$7.154.6% of flowCommon StockSEC:0001077183-18-000019:1
  • ◇
    CIOExecutivesNeogenomics Inc
    162,928 USD11SEC
    21,666 shares@ US$7.523.9% of flowCommon StockSEC:0001077183-18-000019:2
  • ▼
    CIOExecutivesNeogenomics Inc
    883,949 USD13SEC
    81,999 shares@ US$10.7821.1% of flowCommon StockSEC:0001077183-18-000019:3
  • ◇
    CIOExecutivesNeogenomics Inc
    147,375 USD11SEC
    37,500 shares@ US$3.933.7% of flowCommon StockSEC:0001209191-17-038136:0
  • ◇
    CIOExecutivesNeogenomics Inc
    159,332 USD11SEC
    33,333 shares@ US$4.784.0% of flowCommon StockSEC:0001209191-17-038136:1
  • ▼
    CIOExecutivesNeogenomics Inc
    114,450 USD23SEC
    15,000 shares@ US$7.632.9% of flowCommon StockSEC:0001209191-17-038136:2
  • ▼
    CIOExecutivesNeogenomics Inc
    77,900 USD23SEC
    10,000 shares@ US$7.792.0% of flowCommon StockSEC:0001209191-17-038136:3
  • ▼
    CIOExecutivesNeogenomics Inc
    357,039 USD24SEC
    45,833 shares@ US$7.799.0% of flowCommon stockSEC:0001209191-17-038136:4
  • ◇
    CIOExecutivesNeogenomics Inc
    86,040 USD11SEC
    18,000 shares@ US$4.782.2% of flowCommon StockSEC:0001209191-16-122335:0
  • ▼
    CIOExecutivesNeogenomics Inc
    153,000 USD23SEC
    18,000 shares@ US$8.503.9% of flowCommon StockSEC:0001209191-16-122335:1
  • ◇
    CIOExecutivesNeogenomics Inc
    71,700 USD11SEC
    15,000 shares@ US$4.781.8% of flowCommon StockSEC:0001209191-16-118827:0
  • ▼
    CIOExecutivesNeogenomics Inc
    123,300 USD23SEC
    15,000 shares@ US$8.223.1% of flowCommon StockSEC:0001209191-16-118827:1
  • ◇
    CIOExecutivesNeogenomics Inc
    442,125 USD12SEC
    112,500 shares@ US$3.9311.1% of flowCommon StockSEC:0001209191-16-117171:0
  • ▼
    CIOExecutivesNeogenomics Inc
    912,375 USD25SEC
    112,500 shares@ US$8.1122.9% of flowCommon StockSEC:0001209191-16-117171:1

15 of 15 declarations